YESENOMA

DEAD

Serial Number

88696459

Owner

SUPERNUS PHARMACEUTICALS, INC.

Attorney

Mark D. Simpson

Filing Date

Nov 18, 2019

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

YESENOMA Trademark

Serial Number: 88696459

YESENOMA is a trademark filed by SUPERNUS PHARMACEUTICALS, INC. on November 18, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

SUPERNUS PHARMACEUTICALS, INC. (49 trademarks)

1550 EAST GUDE DRIVE
ROCKVILLE, MD 20850

Entity Type: 03

Legal Representation

Attorney of Record

Mark D. Simpson

685 trademarks filed View all →

Trademark Details

Filing Date

November 18, 2019

Registration Date

Not Registered

Published for Opposition

May 26, 2020

Goods & Services

Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Aug 21, 2023 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Aug 21, 2023 ABN6

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 23, 2022 EXRA

SOU EXTENSION 5 GRANTED

Dec 22, 2022 EX5G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 22, 2022 AITU

SOU EXTENSION 5 FILED

Dec 8, 2022 EXT5

SOU TEAS EXTENSION RECEIVED

Dec 8, 2022 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 23, 2022 EXRA

SOU EXTENSION 4 GRANTED

Jul 21, 2022 EX4G

SOU EXTENSION 4 FILED

Jul 21, 2022 EXT4

SOU TEAS EXTENSION RECEIVED

Jul 21, 2022 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 25, 2022 EXRA

SOU EXTENSION 3 GRANTED

Jan 21, 2022 EX3G

SOU EXTENSION 3 FILED

Jan 21, 2022 EXT3

SOU TEAS EXTENSION RECEIVED

Jan 21, 2022 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 23, 2021 EXRA

SOU EXTENSION 2 GRANTED

Jul 21, 2021 EX2G

SOU EXTENSION 2 FILED

Jul 21, 2021 EXT2

SOU TEAS EXTENSION RECEIVED

Jul 21, 2021 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 23, 2021 EXRA

SOU EXTENSION 1 GRANTED

Jan 21, 2021 EX1G

SOU EXTENSION 1 FILED

Jan 21, 2021 EXT1

SOU TEAS EXTENSION RECEIVED

Jan 21, 2021 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jul 21, 2020 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 26, 2020 NPUB

PUBLISHED FOR OPPOSITION

May 26, 2020 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 6, 2020 NONP

ASSIGNED TO LIE

Apr 22, 2020 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 13, 2020 CNSA

EXAMINER'S AMENDMENT ENTERED

Apr 13, 2020 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Apr 13, 2020 GNEN

EXAMINERS AMENDMENT E-MAILED

Apr 13, 2020 GNEA

EXAMINERS AMENDMENT -WRITTEN

Apr 13, 2020 CNEA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 28, 2020 GNRN

NON-FINAL ACTION E-MAILED

Feb 28, 2020 GNRT

NON-FINAL ACTION WRITTEN

Feb 28, 2020 CNRT

ASSIGNED TO EXAMINER

Feb 21, 2020 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 23, 2019 NWOS

NEW APPLICATION ENTERED

Nov 21, 2019 NWAP

Related Trademarks

More from this Owner

ONCE-A-DAY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES

ONCE-A-DAY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

More in Same Class

ENJOYHEALTH

ONEFIT

NOURISHING NUTRIENTS

KSMILE

HONEYGIZER